Wie hoch ist der Preis für GSK plc (GSK)

Preis für GSK plc (GSK) ist $25.28

Wie hoch ist die Marktkapitalisierung für GSK plc (GSK)

Marktkapitalisierung für GSK plc (GSK) ist $1.01B

GSK plc (GSK) Aktiensplits

GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.

Jahr	Aktien-Split	Multiplikator	Kumulierter Multiplikator
2022-07-22	4:5	x0.8	x10.24
2022-07-19	4:5	x0.8	x12.8
1991-11-12	2:1	x2	x16
1986-01-27	2:1	x2	x8
1983-02-22	2:1	x2	x4
1980-02-13	2:1	x2	x2

Jahr

Aktien-Split

Multiplikator

Kumulierter Multiplikator

2022-07-22

4:5

x0.8

x10.24

2022-07-19

4:5

x0.8

x12.8

1991-11-12

2:1

x16

1986-01-27

2:1

1983-02-22

2:1

1980-02-13

2:1

Unternehmen	Anzahl der Aktiensplits	Kumulierter Multiplikator	Land
Eli Lilly and Company LLY.US	4	x15	US
Johnson & Johnson JNJ.US	7	x432	US
AbbVie Inc. ABBV.US	0	-	US
Roche Holding AG RO.SW	2	x10000	CH
Merck & Co., Inc. MRK.US	7	x226	US

Unternehmen

Anzahl der Aktiensplits

Kumulierter Multiplikator

Land